The weak interaction of LcrV and TLR2 does not contribute to the virulence of Yersinia pestis

Microbes and Infection

Volumn 9, Issue 8, 2007, Pages 997-1002

  Reithmeier Rost, Dagmar ^a   Hill, Jim ^b   Elvin, Stephen J ^b   Williamson, Diane ^b   Dittmann, Svea ^a   Schmid, Annika ^a   Wilharm, Gottfried ^a   Sing, Andreas ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^c BAVARIAN HEALTH AND FOOD SAFETY AUTHORITY   (Germany)

Author keywords

Immunomodulation; Plague; Toll like receptors

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; LCRV ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE INDUCTION; IMMUNOMODULATION; INFLAMMATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PLAGUE; PRIORITY JOURNAL; SEROTYPE; STATISTICAL SIGNIFICANCE; SURVIVAL; WILD TYPE; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

MUS; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 34250649344     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2007.04.003     Document Type: Article

References (28)

1. Burrows T.W. An antigen determining virulence in Pasteurella pestis. Nature 177 (1956) 426-427
2. Cornelis G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3 (2002) 742-752
3. Aepfelbacher M., Zumbihl R., Ruckdeschel K., Jacobi C.A., Barz C., and Heesemann J. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol. Chem. 380 (1999) 795-802
4. Brubaker R.R. Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen). Infect. Immun. 71 (2003) 3673-3681
5. 2+ response virulence genes. J. Bacteriol. 173 (1991) 2649-2657
6. Matson J.S., and Nilles M.L. LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis. J. Bacteriol. 183 (2001) 5082-5091
7. Motin V.L., Nakajima R., Smirnov G.B., and Brubaker R.R. Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide. Infect. Immun. 62 (1994) 4192-4201
8. Nedialkov Y.A., Motin V.L., and Brubaker R.R. Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10. Infect. Immun. 65 (1997) 1196-1203
9. Sing A., Roggenkamp A., Geiger A.M., and Heesemann J. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168 (2002) 1315-1321
10. Sing A., Rost D., Tvardovskaia N., Roggenkamp A., Wiedemann A., Kirschning C.J., Aepfelbacher M., and Heesemann J. Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196 (2002) 1017-1024
11. Sing A., Tvardovskaia N., Rost D., Kirschning C.J., Wagner H., and Heesemann J. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model. Int. J. Med. Microbiol. 293 (2003) 341-348
12. Sing A., Reithmeier-Rost D., Granfors K., Hill J., Roggenkamp A., and Heesemann J. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence. Proc. Natl. Acad. Sci. USA. 102 (2005) 16049-16054
13. Reithmeier-Rost D., Bierschenk S., Filippova N., Schröder-Braunstein J., and Sing A. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner. Cell. Immunol. 231 (2004) 63-74
14. Leary S.E.C., Williamson E.D., Griffin K.F., Russell P., Eley S.M., and Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63 (1995) 2854-2858
15. Pettersson J., Holmstrom A., Hill J., Leary S., Frithz-Lindsten E., von Euler-Matell A., Carlsson E., Titball R., Forsberg A., and Wolf-Watz H. The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation. Mol. Microbiol. 32 (1999) 961-976
16. Roggenkamp A., Geiger A.M., Leitritz L., Kessler A., and Heesemann J. Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen. Infect. Immun. 65 (1997) 446-451
17. Overheim A., Depaolo R.W., DeBord K.L., Morrin E.M., Anderson D.M., Green N.M., Brubaker R.R., Jabri B., and Schneewind O. LcrV plague vaccine with altered immunomodulatory properties. Infect. Immun. 73 (2005) 5152-5159
18. Hill J., Leary S.E., Griffin K.F., Williamson E.D., and Titball R.W. Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect. Immun. 65 (1997) 4476-4482
19. Russell P., Eley S.M., Hibbs S.E., Manchee R.J., Stagg A.J., and Titball R.W. A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model. Vaccine 13 (1995) 1551-1556
20. Locher M., Lehnert B., Krauss K., Heesemann J., Groll M., and Wilharm G. Crystal structure of the Yersinia enterocolitica type III secretion chaperone SycT. J. Biol. Chem. 280 (2005) 31149-31155
21. Schmid A., Dittmann S., Grimminger V., Walter S., Heesemann J., and Wilharm G. Yersinia enterocolitica type III secretion chaperone SycD: recombinant expression, purification and characterization of a homodimer. Protein Expr. Purif. 49 (2006) 176-182
22. van Erp K., Dach K., Koch I., Heesemann J., and Hoffmann R. Role of strain differences on host resistance and the transcriptional response of macrophages to infection with Yersinia enterocolitica. Physiol. Genomics. 25 (2006) 75-84
23. Derewenda U., Mateja A., Devedjiev Y., Routzahn K.M., Evdokimov A.G., Derewenda Z.S., and Waugh D.S. The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague. Structure 12 (2004) 301-306
24. Takeuchi J., Wataria E., Shinyaa E., Norosea Y., Matsumotoc M., Seyac T., Sugitaa M., Kawanab S., and Takahashi H. Down-regulation of Toll-like receptor expression in monocyte-derived Langerhans cell-like cells: implications of low-responsiveness to bacterial components in the epidermal Langerhans cells. Biochem. Biophys. Res. Commun. 306 (2003) 674-679
25. Mitsui H., Watanabe T., Saeki H., Mori K., Fujita H., Tada Y., Ashina A., Nakamura K., and Tamaki K. Differential expression and function of Toll-like receptors in Langerhans cells: comparison with splenic dendritic cells. J. Invest. Dermatol. 122 (2004) 95-102
26. de Saint-Vis B., Fugier-Vivier I., Massacrier C., Gaillard C., Vanbervliet B., Ait-Yahia S., Banchereau J., Liu Y.-J., Lebecque S., and Caux C. The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation. J. Immunol. 160 (1998) 1666-1676
27. Mowat A.M. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3 (2003) 331-341
28. Iwasaki A., and Kelsall B.L. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J. Exp. Med. 190 (1999) 229-239